Page last updated: 2024-08-23

staurosporine and THZ531

staurosporine has been researched along with THZ531 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aparicio, SA; Araki, S; Endo, S; Imaeda, Y; Ito, M; Kawamoto, T; Klein, MG; Kokubo, H; Kondo, M; Maezaki, H; Morin, GB; Morishita, N; Murakami, M; Nakanishi, A; Sameshima, T; Tanaka, T; Toita, A; Uchiyama, N; Zou, H	1

Other Studies

1 other study(ies) available for staurosporine and THZ531

Article	Year
Discovery of 3-Benzyl-1-( trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) Inhibitors. Journal of medicinal chemistry, 2018, 09-13, Volume: 61, Issue:17 Topics: Breast Neoplasms; Cell Survival; Cyclin-Dependent Kinases; Drug Discovery; Enzyme Inhibitors; Female; Humans; Phosphorylation; RNA Polymerase II; Structure-Activity Relationship; Tumor Cells, Cultured	2018

Article

Year

Discovery of 3-Benzyl-1-( trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) Inhibitors.

Journal of medicinal chemistry, 2018, 09-13, Volume: 61, Issue:17

Topics: Breast Neoplasms; Cell Survival; Cyclin-Dependent Kinases; Drug Discovery; Enzyme Inhibitors; Female; Humans; Phosphorylation; RNA Polymerase II; Structure-Activity Relationship; Tumor Cells, Cultured

2018